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ABSTRACT
Pyrrole–imidazole polyamides targeted to the andro-
gen response element were cytotoxic in multiple cell
lines, independent of intact androgen receptor sig-
naling. Polyamide treatment induced accumulation
of S-phase cells and of PCNA replication/repair foci.
Activation of a cell cycle checkpoint response was
evidenced by autophosphorylation of ATR, the S-
phase checkpoint kinase, and by recruitment of ATR
and the ATR activators RPA, 9-1-1, and Rad17 to chro-
matin. Surprisingly, ATR activation was accompanied
by only a slight increase in single-stranded DNA,
and the ATR targets RPA2 and Chk1, a cell cycle
checkpoint kinase, were not phosphorylated. How-
ever, ATR activation resulted in phosphorylation of
the replicative helicase subunit MCM2, an ATR effec-
tor. Polyamide treatment also induced accumulation
of monoubiquitinated FANCD2, which is recruited to
stalled replication forks and interacts transiently with
phospho-MCM2. This suggests that polyamides in-
duce replication stress that ATR can counteract in-
dependently of Chk1 and that the FA/BRCA pathway
may also be involved in the response to polyamides.
In biochemical assays, polyamides inhibit DNA heli-
cases, providing a plausible mechanism for S-phase
inhibition.
INTRODUCTION
Many DNA-binding small molecules can challenge a cell’s
ability to accurately replicate its DNA. Tolerance to various
forms of replication stress is possible with the aid of stress
sensors andmediators that activate DNA repair and cell cy-
cle pathways, collectively called the DNA damage response
(DDR) (1). Themaster regulators of theDDRareATR and
ATM, two PI3 protein kinase family members, which re-
spond to stalled replication forks and DNA breaks. ATR
and ATM phosphorylate many substrates to stabilize the
DNA replication fork and activate cell cycle checkpoints.
The checkpoints slow cell cycle progression and allow time
for the cell to respond to stress before entry into mitosis (2).
During S-phase, ATR is recruited to sites of stalled replica-
tion by replication protein A (RPA)-bound single-stranded
DNA (ssDNA) in the presence of DNA damage. ATR is
activated by a complex of many proteins and phosphory-
lates a number of targets, among which Chk1, a cell cycle
checkpoint kinase, is best understood (3,4). ATM is simi-
larly recruited to sites of double-stranded breaks (DSBs) by
the Mre11–Rad50–NBS1 complex, where it can phospho-
rylate Chk2, another cell cycle checkpoint kinase, and the
histone variantH2AX (5).However, how theDDR reacts to
specific types of stresses, what downstream signaling events
are necessary and what physical structures are sensed is still
under investigation (6). Furthermore, there are many levels
of crosstalk between ATM and ATR and many targets be-
yond the checkpoint kinases, Chk1 and Chk2, which adds
to the complexity (4). We have studied the checkpoint re-
sponse activated by DNA minor groove binding pyrrole–
imidazole (Py–Im) polyamides to discover what response
polyamides elicit.
Py–Im polyamides are programmable small molecules
that bind in the minor groove of double-strandedDNA (ds-
DNA) with affinities and specificities comparable to DNA-
binding proteins (7,8). Binding of the polyamides alters
the local helical structure of DNA (9). Eight-ring hair-
pin polyamides are cell permeable and localize to the nu-
cleus in live cells (10). Py–Im polyamides are derived from
the natural products distamycin A and netropsin (11). Dis-
tamycin A is cytotoxic at relatively high concentrations (12)
and inhibits the activity of RNA polymerase, DNA poly-
merase, topoisomerases I and II and helicases (13–15). Pre-
viously, we showed that hairpin Py–Impolyamides designed
to bind the androgen response element (ARE) decrease the
expression of prostate cancer-related genes, inhibit RNA
polymerase activity, upregulate p53 and induce apoptosis
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(16,17). Curiously, no evidence of DNA breaks was ob-
served which usually occurs upon treatment with DNA
damaging agents such as doxorubicin. However, effects on
replication remain to be investigated.
Here we report that hairpin Py–Im polyamides targeted
to the ARE cause replication stress, resulting in an ac-
cumulation of S-phase cells. Furthermore, the polyamide-
induced checkpoint response activates ATR and down-
stream phosphorylation of the mini-chromosome mainte-
nance complex (MCMs), but not the downstream ATR ef-
fector kinase Chk1. The checkpoint response also results
in monoubiquitination of the Fanconi anemia/breast can-
cer (FA/BRCA) gateway protein FANCD2. The check-
point is activated despite low levels of ssDNA formation
and the absence of observable DNA breaks. We also show
that polyamides are potent inhibitors of helicase unwind-
ing in vitro, suggesting a model in which polyamides pre-
clude fork progression throughDNAbinding. These results
demonstrate that polyamides are capable of imposing repli-
cation stress and can activate both a non-canonical Chk1-
independent ATR-checkpoint response and the FA/BRCA
pathway, resulting in S-phase delay.
MATERIALS AND METHODS
Chemicals and reagents
Hairpin Py–Im polyamides 1 and 2 were synthesized on
solid phase Kaiser oxime resin using previously published
protocols (18). Gemcitabine, etoposide, hydroxyurea (HU)
and doxorubicin were purchased from Sigma-Aldrich, as
were all other reagents unless otherwise noted.
Antibodies purchased from Santa Cruz Biotech were:
mouse anti-PCNA, anti-Chk1, anti-RPA2, anti-Rad17,
anti-FANCD2, goat anti-ATR and rat anti-BrdU (CldU
cross-reactivity). Antibodies purchased from Bethyl were:
rabbit anti-H2AX, anti-MCM2, anti-MCM2pS108 and
anti-RPA2pS4/S8. Antibodies purchased from Abcam
were: rabbit anti-FANCD2, anti-MCM2pS108, anti-Rad9,
anti-RPA2pS33, anti-Chk2 and anti-H2AXpS139. An-
tibodies purchased from Cell Signaling Technologies
were: rabbit anti-ATMpS1981, anti-Rad17pS645, anti-
Chk1pS345, anti-Chk1pS317 and anti-Chk1pS296. Rab-
bit anti-Chk2pT68 was purchased from Millipore. Rabbit
anti-ATM was purchased from Calbiochem. Rabbit anti-
ATRpT1989 was a gift of Prof. Lee Zou.
Cell culture conditions
LNCaP, LNARandDU145 cells weremaintained inRPMI
1640 (Invitrogen) with 10% Fetal Bovine Serum (FBS)
(Irvine Scientific) at 37◦C under 5% CO2. LNCaP and
DU145 cells were purchased from ATCC (Manassas, VA,
USA). LNAR cells were a gift from C.L. Sawyers atMemo-
rial Sloan-Kettering Cancer Center (New York, NY, USA).
Cytotoxicity assay
IC50 values for cytotoxicity were determined using a
sulforhodamine-based colorimetric assay for cellular pro-
tein content in 96-well microplates (19). LNCaP andLNAR
cells were plated at 3000 or 4000 cells per well for the 72-h
and 96-h time points, respectively. DU145 cells were plated
at 2000 or 2500 cells per well. Polyamides were added in
100-l RPMI 1640 supplemented with 10% FBS 24 h after
plating. Quadruplicate wells were used for each concentra-
tion. Cells were fixed with 100-l 10% trichloroacetic acid
solution, washed, stained and dried as described. After sol-
ubilization of the bound dye in 10-mM Tris (pH 8), the ab-
sorbance was measured at 490 nm on a Victor microplate
reader (PerkinElmer).
The cytotoxicity data are charted as a percentage of un-
treated controls, corrected for background absorbance. IC50
is defined as the concentration that inhibits 50% of con-
trol cell growth. These values were determined by nonlinear
least-squares regression fit toY=A+ (B−A)/(1 + 10∧((Log
EC50−X)*H, whereA=max,B=min andH=Hill Slope.
Three independent trials were averaged; stated IC50 values
represent the mean and standard deviation. These calcula-
tions were performed using Prism 4 (GraphPad) software.
Caspase 3/7 activation assay
DU145 cells were plated in 96-well microplates at 2000–
8000 cells per well. As above, polyamides and controls were
added 24 h after plating. Each time point was assayed in
triplicate. At harvest, Caspase 3/7 activity was assessed
using 100 l of Caspase-Glo reagent (Promega), which
contains the proluminescent caspase substrate DEVD-
aminoluciferin. Luminescence was measured after 30-min
incubation at room temperature. Luminescence data are ex-
pressed as a fold difference from untreated controls as mea-
sured using a Victor microplate reader (PerkinElmer).
The cell viability of each treatment condition was mon-
itored in a sister plate using a tetrazolium-based assay for
mitochondrial bioreductive capacity (20). Ten-microliter
WST-1 reagent (Roche) was added to each well and incu-
bated at 37◦C for 30 min before measuring the absorbance
at 450 nm. The WST-1 data are corrected for background
absorbance and expressed as a percentage of untreated con-
trols.
PARP cleavage assay
400 000 DU145 cells were plated in 10-cm diameter dishes.
Polyamides were added after 24 h and were allowed to in-
cubate an additional 72 h. At harvest, cells were washed
once with phosphate buffered saline (PBS) then treated
with 400-l ice-cold lysis buffer (20-mM Tris-HCl pH 7.5,
150-mMNaCl, 1-mMNa2 ethylenediaminetetraacetic acid
(EDTA), 1-mM ethylene glycol tetraacetic acid (EGTA),
1% Triton, 2.5-mM sodium pyrophosphate, 2-mM -
glycerophosphate, 1-mM Na3VO4, 1-g/ml leupeptin, 1-
mM phenylmethylsulfonyl fluoride (PMSF)) for 5 min at
5◦C. The lysate was sonicated for 15 s and then centrifuged
for 10 min at 20 000 × g at 5◦C. The supernatant was re-
tained. Protein concentrations were determined by Brad-
ford assay (Bio-Rad) using bovine serum albumin (BSA;
Bio-Rad) to create a standard curve. PARP cleavage was
assayed by sandwich ELISA (Cell Signaling Technology)
and performed according to the manufacturer’s recom-
mendations. Ten-microgram total protein was loaded into
each well of a microplate coated with anti-cleaved PARP
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(Asp214) mouse mAb and allowed to incubate overnight at
5◦C. Rabbit anti-PARP mAb was then added, followed by
anti-rabbit IgG conjugated to horseradish peroxidase. Trip-
licate wells were included for each condition, and the data
are representative of both experimental replicates. The data
are expressed as fold change from the untreated condition,
showing the mean and standard deviation of each measure-
ment.
Cell cycle analysis
800 000 DU145 cells were plated in 10-cm diameter dishes
for 24 h before treatment with polyamides for an additional
24 h. Cells were pulsed with 10-M ethynyldeoxyuridine
(EdU) 30 min before harvest to estimate the rate of DNA
synthesis. Cells were trypsinized and pelleted at 300 × g
with cell culture supernatant. Following overnight fixation
in 70% ethanol, the cells were rehydrated in 1% BSA/PBS
and processed with the Click-it EdU Alexa Fluor 488 Flow
Cytometry assay kit (Invitrogen) using half the recom-
mended A488 reagent. After overnight treatment with 0.2-
mg/ml RNase A in 1% BSA/PBS, the cells were stained for
DNA content with 7-aminoactinomycinD and analyzed on
a FACSCalibur (Becton-Dickinson) instrument. The data
were analyzed using FlowJo v9.5.3 (TreeStar) and are rep-
resentative of two trials. Monoparametric, propidium io-
dide, flow cytometry was also used to evaluate the effect of
polyamides 1 and 2 on cell cycle distribution. DU145 cells
were treated with 1–100 M of polyamide 1 or 0.1–10 M
of polyamide 2 for 48 h. The effect of PI3 kinases on cell cy-
cle distribution was measured by treating DU145 cells with
10-M polyamide 1 or 1-M polyamide 2 as well as 2-mM
caffeine, 4- or 10-M NU6027 (Calbiochem) and 4- or 10-
M KU55933 (Calbiochem) for 36 h. Data were analyzed
using FlowJo and fitted to the Watson (Pragmatic) model.
The data are representative of two trials.
Knockdown of ATR by siRNA
ATR was knocked down for cell cycle analysis and im-
munoblot experiments using 20-nM Silencer Select siRNA
against ATR (Ambion, s536) and RNAiMAX lipofec-
tamine (Life Technologies) according to the manufacturer’s
protocol. Twenty-nanomolar Silencer Select Negative Con-
trol #1 (Ambion) was used as a control. Briefly, the siRNA
was incubated for 48 h, with a media swap after the first
24 h, prior to the addition of 10-M polyamide 1 or 1-M
polyamide 2 for an additional 36 h. Efficiency of knock-
down was determined by western blot.
Proliferating cell nuclear antigen immunocytochemistry
Proliferating cell nuclear antigen (PCNA) immunocyto-
chemistry experiments were performed as in (21). Briefly,
DU145 cells were plated in 4-well glass chamber slides (Lab-
Tek) at 70 000 cells per well. Polyamide 1 was added at a fi-
nal concentration of 10 M and polyamide 2 at a final con-
centration of 1 Mwith 0.2% dimethyl sulfoxide (DMSO).
After fixation, permeabilization and blocking, cells were in-
cubated with mouse PCNA mAb at a 1:500 dilution at 4◦C
overnight. Cells were then washed, followed by incubation
with Alexa Fluor 488-conjugated donkey anti-mouse IgG
(Life Technologies) at a 1:400 dilution at room tempera-
ture for 2 h. Cells were washed and mounted with Pro-
long Gold Anti-Fade reagent with DAPI (Life Technolo-
gies). Images were obtained using a Zeiss LSM 510 Meta
NLO with Coherent Chameleon and a Plan-Apochromat
63x 1.4-numerical aperture oil immersion objective lens and
processed using the LSM Browser software package. Foci
were counted using the open source Python software, Fo-
ciCounter (http://focicounter.sourceforge.net/). Parameters
were kept constant across all conditions for a particular
replicate, but differed slightly over the three replicates to ac-
count for differences in staining. Cells that were likely pos-
itive but sufficiently out of focus so as to not produce dis-
tinct foci were not counted. The Kruskal–Wallis test was
performed using Prism 4 (Graphpad) software.
Assessment of phosphorylation of proteins by immunoblot
800 000 DU145 cells were plated in 10-cm diameter dishes
and allowed to adhere for 24 h before treatment with 0.1%
DMSO, polyamide 1 or polyamide 2 for the indicated time.
Cells were lysed in TBS-Tx buffer (50-mMTris-HCl pH 7.4,
150-mM NaCl, 1-mM EDTA, 1% Triton X-100) contain-
ing fresh protease inhibitors (Roche), 1-mM PMSF, phos-
phatase inhibitors and 10-mMN-ethylmaleimide. The sam-
ples were quantified by Bradford assay, denatured by boil-
ing in Laemmli buffer, and total protein was separated by
sodium dodecyl sulphate-polyacrylamide gel electrophore-
sis (SDS-PAGE) on 4–15% gradient polyacrylamide gels
(Bio-Rad). After transfer to the nitrocellulose (Bio-Rad) or
PVDF (Millipore) membrane and blocking with Odyssey
Blocking Buffer (Li-Cor), primary antibodies were incu-
bated overnight at 4◦C. Donkey anti-rabbit, donkey anti-
mouse or donkey anti-goat 800CW IR dye-conjugated sec-
ondary antibody (Li-Cor) was added and the bands were
visualized on an Odyssey infrared imager (Li-Cor). For
assessment of MCM2 and FANCD2 modification, plates
treated with either DMSO, polyamide 1, polyamide 2 or
polyamide plus 2-mM caffeine, 10-M KU55933 (KU,
ATM inhibitor) or 10-M NU6027 (NU, ATR inhibitor)
were added together and harvested at the indicated times.
For HU treatment, cells were incubated with the indicated
inhibitor for 34 h prior to the addition of HU for the final
2 h before harvesting at 36 h. ATR immunoprecipitation
was performed using pre-cleared Protein G agarose beads
(Pierce) and either normal goat IgG or ATR (N19) anti-
bodies (Santa Cruz) overnight at 4oC. All immunoblots and
accompanying quantifications are representative of at least
two biological replicates.
Chromatin fractionation assay
2 × 106 DU145 cells were plated in 15-cm diameter dishes
and allowed to adhere for 24 h, followed by treatment with
0.1% DMSO, 10-M polyamide 1, 1-M polyamide 2 or
10-mM HU for indicated times. Chromatin fractions were
prepared according to published protocols (22). Briefly,
cells were harvested, washed with PBS and resuspended
with 400-l buffer A (10-mM HEPES pH 7.9, 10-mM
KCl, 1.5-mMMgCl2, 0.34-M sucrose, 10% glycerol, 1-mM
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dithiothreitol (DTT) and fresh protease and phosphatase
inhibitors). TritonX-100 was added to a final concentration
of 0.1% and incubated on ice for 5 min followed by centrifu-
gation at 1300× g for 4 min to pellet the nuclei. Nuclei were
washed with buffer A and then lysed with 400-l buffer B
(3-mM EDTA, 0.2-mM EGTA, 1-mMDTT) for 10 min on
ice. Chromatin was pelleted by centrifugation at 1700 × g
for 4 min. Isolated chromatin was washed once with buffer
B and spun down at 10 000 × g for 1 min. The supernatant
is completely removed and the chromatin pellet was resus-
pended in 300-l SDS sample buffer and sheared for 20 s
at 25% amplitude with a microtip adapter. Samples were
then incubated at 80oC and analyzed by SDS-PAGE and
immunoblot.
5-chloro-2′-deoxyuridine immunocytochemistry
20 000 or 50 000 DU145 cells were plated in 4-well glass
chamber slides and allowed to adhere for 24 h. Cells were
incubated with 50-M CldU for 48 h then the media was
swapped and polyamide added. Following polyamide treat-
ment, cells were washed, fixed with 2% formaldehyde (Ted
Pella) and permeabilized with 0.2% Triton X-100. Follow-
ing permeabilization, cells were blockedwith 3% goat serum
with 0.1% Triton for 45 min at room temperature. After
blocking, cells were washed with 0.1%Triton and then incu-
bated with rat anti-BrdU antibody (ICR1) at a concentra-
tion of 10g/ml in 3% goat serum for 30min at 37oC. After
washes, cells were incubated with chicken anti-rat Alexa488
antibody at a concentration of 4 g/ml. Finally, cells were
washed and mounted then imaged as in PCNA staining
above. Cells were scored as positive for ssDNA if >10 foci
were counted. One hundred and fifty cells were counted per
condition over three biological replicates.
Single cell alkaline gel electrophoresis
The apparatus and reagent kit were purchased from Tre-
vigen. The assay was performed according to the manu-
facturer’s recommendations. Briefly, 800 000 DU145 cells
were plated in 10-cm diameter dishes for 24 h before treat-
ment with polyamides for an additional 36 h. Cells were har-
vested by trypsinization and washed once with cold PBS be-
fore being suspended in 37◦C low-melting point agarose at
1 × 105 cells/ml. An aliquot of the suspension was placed
on a 37◦C glass slide and allowed to cool for 30 min. The
slides were bathed in lysis buffer for 30 min followed by a
30-min treatment with alkaline unwinding buffer (200-mM
NaOH, 1-mM EDTA) at 5◦C. The slides were subjected to
electrophoresis at 21 V in a prechilled apparatus and fresh
unwinding buffer for 30 min. The slides were washed twice
in water and once in 70% ethanol, then dried for 30 min at
37◦C. Dried slides were stained with 1X SYBR Gold in TE
buffer for 30 min at room temperature, and excess dye was
removed by blotting. Slides were dried and stored at room
temperature with desiccant. Comets were visualized using a
Zeiss LSM 510 Meta NLO confocal microscope with a 5x
objective (Zeiss) and scored using Comet Assay IV image
analysis software (Perceptive). A random sampling of 400
cells from two biological replicates was analyzed for each
condition. The data are displayed as a box and whisker di-
agram showing median and middle quartiles with whiskers
at the min and max.
T7 gp4A helicase assays
Helicase assays using T7 gp4A (BioHelix) were performed
as published in (23). First, 40 pmol of a 75-mer oligonu-
cleotide was labeled with [ -32P]ATP (MP Biomedicals)
using T4 polynucleotide kinase (NEB) and annealed to
80 pmol of a 95-mer oligonucleotide with 56 complemen-
tary bases to form a forked substrate in STE buffer (100-
mM NaCl, 10-mM Tris-HCl, 1-mM EDTA). The forked
substrate was purified by extraction from a 10% non-
denaturing acrylamide gel. To assess polyamide effects on
gp4A helicase activity, the forked substrate (1:1000 dilution
final) was incubated in a 10-l volume with increasing con-
centrations of polyamide 1 (DMSO solution, 5% final con-
centration) in 1x reaction buffer (BioHelix) for 1 h at room
temperature prior to addition of gp4A at a final concentra-
tion of 143 ng/ml (∼2.27 nM) and incubated at 30◦C for
10 min. The mock-treated helicase reaction contained 5%
DMSO with no polyamide. Reactions were stopped with
the addition of 5-l stop buffer (60-mm EDTA, 40% su-
crose, 0.6% SDS, 0.25% bromphenol blue and 0.25% xylene
cyanole FF). Unwound-labeled single-stranded 75 mer was
separated from the intact fork substrate on a pre-run 10%
non-denaturing acrylamide gel at 200 V for 1 h. The gel was
then placed on a PhosphorImager screen (Molecular Dy-
namics) overnight and imaged on a Storm Molecular Im-
ager. Match 75mer: 5′-CGC CGG GTA CCG AGC TCG
AAT TCA CTG GCC GTC GTT TTA CAA CGT CGT
GAACTGCCT19-3′. Match 95mer: 5′-T39GGCAGT TCA
CGA CGT TGT AAA ACG ACG GCC AGT GAA TTC
GAG CTC GGT ACC CGG CG-3′. Mismatch 75mer: 5′-
CGC CGG GTA CCG AGC TCG AAT TCA CTG GCC
GTC GTT TTA CAA CGT CGT GAC ATG CCT19-3′.
Mismatch 95mer: 5′-T39GGC ATG TCA CGA CGT TGT
AAA ACG ACG GCC AGT GAA TTC GAG CTC GGT
ACC CGG CG-3′.
S. cerevisiae Dna2-K677R helicase assay
Saccharomyces cerevisiae K677R Dna2 (yDna2-K677R),
lacking nuclease activity, was prepared and helicase assays
were performed similar to (24). First, 40 pmol of a 42-mer
oligonucleotide was labeled with [ -32P]ATP (MP Biomed-
icals) and annealed to 80 pmol of a 29-mer oligonucleotide
with 24 complementary bases to form a forked substrate in
STE buffer. To assess polyamide effects on yDna2-K677R
helicase activity, the forked substrate (1:2000 dilution final)
was incubated in a 20-l volume with increasing concentra-
tions of polyamide 1 (DMSO solution, 5% final concentra-
tion) in 1x reaction buffer (25-mmTris-HCl (pH 7.5), 2-mM
MgCl2, 2-mm DTT, 0.25-mg/ml BSA, 2-mM adenosine
triphosphate (ATP)) for 1 h at room temperature prior to
addition of 150-fmol yDna2-K667R and incubated at 37◦C
for 30 min. The mock-treated helicase reaction contained
5%DMSOwith no polyamide.Reactionswere stoppedwith
the addition of 5-l stop buffer. Unwound-labeled single-
stranded 42 mer was separated from the intact fork sub-
strate on a pre-run 20% non-denaturing acrylamide gel run
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at 150 V for 3 h. The gel was then placed on a Phospho-
rImager screen overnight and imaged on a StormMolecular
Imager. Match 42mer: 5′-AGC TAG CTC TTG ATCGTG
ACG AGA ACA CCA GAA CGA GTA GTA-3′. Match
29mer 5′-TAC TAC TCG TTC TGG TGT TCT CGT TGA
TC-3′. Mismatch 42mer: 5′-AGC TAG CTC TTG ATC
GTG ACG AGA AAA CCA GAA CGA GTA GTA-3′.
Mismatch 29mer 5′-TAC TAC TCG TTC TGG TTT TCT
CGT TGA TC-3′.
S. cerevisiae Dna2-K677R ATPase assay
The ATPase assay was run as in (24). Briefly, reactions con-
taining 300 fmol of yDna2-K677R protein in 20 l of re-
action buffer (40-mM Tris-HCl (pH 7.5), 5-mM MgCl2,
25-mM NaCl, 1-mM DTT, 0.5-mg/ml BSA, 0.2-mM ATP,
10% glycerol and 3 Ci of [ -32P]ATP) were supplemented
with the mismatch 42-mer plus DMSO or 3-Mpolyamide
1 and incubated at 30◦C for 1 h. The reactions were stopped
by addition of EDTA. An amount of 0.8 l of each reac-
tion was spotted onto a polyethyleneimine-cellulose TLC
plate (Selecto Scientific) and developed in 0.5-M LiCl, 1-
M formic acid solution. The radiolabeled products were de-
tected by PhosphorImager.
Clonogenic assays
Clonogenic assays were performed with FANCD2-deficient
PD20 cells complemented with empty vector (PD20-EV)
or FANCD2 (PD20-FANCD2). FANCD2 protein expres-
sion and phenotype rescue was previously confirmed (25).
Briefly, 1000 cells per well were seeded in a 12-well plate and
left to attach overnight. Polyamide 1 (0, 10, 20, 30 M) or
polyamide 2 (0, 1, 2, 3 M) was added for 36 h. Polyamide-
containing media was exchanged for fresh media and cells
were cultured for 14 days with media changed every 4 days.
Visible colonies were fixed and stained with 1% crystal vio-
let in methanol and enumerated. Three independent exper-
iments were performed.
RESULTS
Py–Im polyamides cause accumulation of S-phase cells and
PCNA foci
Hairpin Py–Im polyamides 1 and 2 were designed to tar-
get the ARE (5′-GGTACANNNTGTTCT-3′ (26)) and an-
tagonize gene expression changes driven by the androgen
receptor (AR) in the prostate cancer cell line, LNCaP (Fig-
ure 1A and B) (16,27). In LNCaP cells, AR signaling plays a
critical role in cell proliferation (28), therefore disruption of
AR-dependent signalingmay contribute to cell death.How-
ever, disruption of other DNA-dependent processes such as
RNA pol II transcription elongation may also cause cell
death. To investigate the effects of polyamides outside of
AR-dependent transcription, we first compared the cyto-
toxicity of polyamides 1 and 2 in three different prostate
cancer cell lines, LNCaP, LNARandDU145, which express
high, normal and low levels of AR, respectively. Polyamides
1 and 2 displayed dose-dependent cytotoxicity at 72 and 96
h as measured by sulforhodamine B staining (Supplemen-
tary Table S1). Polyamide 2 had ∼10-fold higher potency
than polyamide 1, which is consistent with its greater po-
tency against AR-driven gene expression (27). Importantly,
the IC50 values were similar in all cell lines regardless of AR
status, suggesting that the observed cytotoxicity occurred
via anAR-independentmechanism. InDU145 cells, expres-
sion of an AR-driven reporter is insensitive to androgen
treatment and AR is minimally expressed (29). Therefore,
DU145 cells provide an environment to investigate the ef-
fects of polyamides 1 and 2 independent of AR signaling.
Next, we examined the effects of polyamides 1 and 2 on
the cell cycle inDU145 cells.We pulse-labeled exponentially
growing and asynchronousDU145 cells withEdUafter 24 h
of polyamide treatment. Both polyamides produced a dose-
dependent increase in the percentage of cells in S-phase,
with a corresponding drop in the percentage of G0/G1 cells
(Figure 1C). Although more cells were in S-phase, the aver-
age intensity of EdU staining decreased, suggesting that the
treated cells were replicating their DNA more slowly and
thus cells spent longer in S-phase (Figure 1D). Similar re-
sults were also obtained using traditional one-color flow cy-
tometry to determine the cell cycle distribution after 48 h of
polyamide treatment (Figure 1E).
We then determined whether replication/repair foci ac-
cumulated in the treated cells using PCNA immunofluores-
cence (21,30). We chose treatment conditions to allow for
maximal effect on the cells before any significant decrease
in viability or activation of apoptosis, as measured by mi-
tochondrial reduction activity and caspase 3/7 activation
(Supplementary Figure S1). Nearly all DMSO-treated cells
showed 0–2 foci per cell, while polyamide treatment resulted
in a significant increase in cells with greater than 20 foci
(Figure 1F and G). Interestingly, some of the polyamide-
treated cells but none of the DMSO-treated cells showed
more than 50 foci. Observation of cells with such high in-
cidence of foci suggests that polyamides cause prolonged
stalling of replication forks and the recruitment of repair
machinery (30).
Py–Im polyamide treatment induces ATR activation
S-phase accumulation subsequent to treatment with a
DNA-binding compound was suggestive of checkpoint
activation in response to replication stress. We therefore
probed for activation of the master regulator kinases, ATR
and ATM. We assayed ATR activation by immunoblotting
for T1989 phosphorylation, an autophosphorylation site
that has been implicated in ATR activation and a robust
checkpoint response (31,32). Cells treated with polyamide
1 or 2 showed a slight increase in ATR T1989 phosphoryla-
tion relative to DMSO-treated cells (Figure 2A). However,
cells treated with HU, which causes nucleotide depletion,
showed greater ATR T1989 phosphorylation compared to
polyamide-treated cells suggesting a weaker activation of
ATR by polyamides. NU6027, which inhibits cellular ATR
but not ATM, did not abrogate T1989 phosphorylation un-
der polyamide treatment (33). While polyamide treatment
appeared to activate ATR, polyamides did not induce ATM
S1981 phosphorylation, an autophosphorylation site that
has been associated with ATM activation and stabilization
at DSBs (Figure 2B) (34).
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Figure 1. Polyamides cause accumulation of S-phase cells and PCNA foci. (A) Chemical structure Py–Im polyamides used in this study. (B) Ball-and-stick
representation of the polyamides. Open circles represent N-methylpyrrole residues and filled circles represent N-methylimidazoles. The hexagon represents
the isophthalic acid moiety. Polyamides 1 and 2 are specific for the same 5′-WGWWCW-3′ DNA sequence, whereW=A or T. (C) Cell cycle distribution of
DU145 cells untreated (UT) or treated with gemcitabine (GCB), polyamide 1 or polyamide 2 for 24 h as measured by two-color flow cytometric evaluation
of EdU pulse-labeled cells stained for DNA content with 7AAD. (D) Dose-dependent decrease in average EdU incorporation indicative of slowed DNA
synthesis in response to polyamide treatment. (E) Cell cycle distribution of DU145 cells untreated or treated with polyamide 1 or 2 for 48 h as measured by
single-color flow cytometric evaluation of propidium iodide stained cells. (F) Representative images of immunofluorescent detection of PCNA in DU145
cells. Treatment with either 10-M polyamide 1 or 1-M 2 for 36 h causes more cells to contain significant punctate staining of PCNA. (G) PCNA foci
counts for each cell are plotted in a histogram with bin sizes of 10 foci for each condition. One hundred and fifty cells over three replicates were counted
for each condition. The Kruskal–Wallis test reports P < 0.0001 for 1 versus DMSO and 2 versus DMSO.
The weak phosphorylation of ATR suggested that
polyamide treatment might result in limited ssDNA for-
mation (4). To directly probe for ssDNA accumulation, we
preincubated cells with the thymidine analog, 5-chloro-2′-
deoxyuridine (CldU), and then treated with polyamide or
HU. After treatment, we fixed the cells and immunostained
using an anti-CldU antibody, which reacts with CldU ex-
posed in ssDNA but not dsDNA. About 25% of cells on
average showed >10 CldU foci after treatment with HU,
while only about 3% and 1% of cells showed>10 CldU foci
after 12-h treatment with high concentrations of polyamide
1 or 2 (Figure 2C and D). When treated with lower concen-
trations of polyamide 1 or 2 for 36 h post-CldU incubation,
about 8%and 9% cells were positive forCldU foci.However,
among the positive cells present under polyamide treatment
the number of CldU foci was substantially lower than in
HU-treated cells. Thus, the degree of ssDNA formation in
polyamide-treated cells was also lower than in HU-treated
cells, consistent with the lower levels of T1989 phosphory-
lation observed.
To confirm ATR activation, we determined if ATR and
mediators of the ATR response accumulate on chromatin
after polyamide treatment. Polyamide treatment resulted in
ATR loading onto chromatin (Figure 2E). Interestingly, al-
though we had observed a lower level of ATR phosphory-
lation in polyamide-treated cells than in HU-treated cells
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Figure 2. Polyamides induce ATR activation without extensive ssDNA formation. (A) Immunoblot of ATRpT1989 and ATR following immunoprecipi-
tation (IP) of ATR in DU145 whole cell lysates treated with 4-mM hydroxyurea (HU) for 2 h, and DMSO, 10-Mpolyamide 1 or 1-Mpolyamide 2 in the
presence or absence of 10-MNU6027 (NU, ATR inhibitor) for 36 h. (B) Immunoblots of ATMpS1981 and ATM after treatment with 30-M etoposide
(Etop) for 30 min, and DMSO, 10-M polyamide 1 or 1-M polyamide 2 in the presence or absence of 10-MKU55933 (KU, ATM inhibitor) for 36 h.
(C) Representative images of ssDNA formation via CldU immunofluorescence under non-denaturing conditions are shown for cells after treatment with
4-mM HU for 2 h, DMSO, 30-M polyamide 1 or 3-M polyamide 2 for 12 h, and 10-M polyamide 1 or 1-M polyamide 2 for 36 h. (D) Bar graphs
of the mean and standard deviation of percent CldU positive cells (>10 foci/cell). One hundred and fifty cells over three replicates were counted for each
condition. (E) Immunoblots of ATR and checkpoint-related factors loaded onto chromatin upon treatment with 10-mMHU for 2 h, and DMSO, 10-M
polyamide 1 or 1-M polyamide 2 for 36 h. (F) DNA histograms of propidium iodide (PI) stained DU145 cells after treatment with negative control or
ATR-targeting siRNA for 48 h followed by treatment with DMSO, 10-M polyamide 1 or 1-M polyamide 2 for 36 h. The percentage of cells in S-phase
is included at the top right of each graph.
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(Figure 2A), similar amounts of ATR were loaded onto
chromatin following each treatment. Polyamide treatment
also induced loading of RPA, the Rad9–Rad1–Hus1 (9-1-
1) complex, which is integral to ATR checkpoint signal-
ing, and Rad17, which is part of the clamp loader that fa-
cilitates 9-1-1 loading, to similar levels as did HU. Rad17
S645, a target forATRphosphorylation that is necessary for
G2 checkpoint activation (35), was phosphorylated in the
presence of polyamide, indicating that ATR was activated.
Polyamide treatment also induced higher PCNA loading on
chromatin, which is consistent with the high incidence of
PCNA foci formation (Figure 1D). Despite the lack of ex-
tensive ssDNA formation, ATR as well as its mediators is
recruited to chromatin and ATR is active after polyamide
treatment.
Py–Im polyamide-induced S-phase delay is not abrogated by
ATR knockdown
To determine whether the activation of ATR had physi-
ological consequences, we monitored the effect of siRNA
knockdown of ATR on accumulation of polyamide-treated
cells in S-phase. The percentage of S-phase cells was the
same in cells treated with either siRNA against ATR or neg-
ative control siRNA prior to treatment with polyamide 1 or
2 (Figure 2F). This suggests that ATR activity is not con-
tributing to S-phase accumulation. When caffeine, a PI3
kinase inhibitor with preference for ATR over ATM, was
added to cells in addition to polyamide 1 or 2, the S-phase
population was reduced compared to cells treated only with
polyamide; however, caffeine treatment also reduces the
basal level of S-phase cells and may account for this de-
crease (Supplementary Figure S2). Similarly, when theATR
inhibitor NU6027 was added to cells the S-phase popu-
lation was reduced under both the basal and polyamide-
treated conditions.
Although ATM S1981 was not phosphorylated in re-
sponse to polyamide treatment, ATMautophosphorylation
sites other than S1981 have been implicated in its activation
and function in the cell cycle checkpoint (36). Therefore the
effects of ATM inhibitionwere alsomonitored.KU55933, a
selective inhibitor of ATM, did not diminish the polyamide-
induced S-phase accumulation (Supplementary Figure S2)
(37).
Py–Im polyamide treatment does not induce Chk1, RPA2 or
Chk2 phosphorylation
The ATR-mediated checkpoint response can be propagated
by a variety of downstream effectors. Chk1, the best stud-
ied of the ATR effectors, signals cell cycle delay after acti-
vation by ATR via phosphorylation at S345. Surprisingly,
Chk1 S345 was not phosphorylated after treatment with
polyamide (Figure 2E). Chk1 S345 phosphorylation is de-
pendent upon RPA2 hyperphosphorylation at sites S4 and
S8, which occurs following DSBs from collapsed replica-
tion forks (38). Polyamide treatment also did not induce
phosphorylation of RPA2 S4/S8. To ensure that we were
not missing a transient activation of Chk1 or RPA2, we as-
sayed for their phosphorylation across multiple time points.
In addition, we monitored other known Chk1 and RPA2
Figure 3. Polyamides do not induce phosphorylation of Chk1, RPA2 or
Chk2 or observable DNA breaks. (A) Immunoblots of phosphorylated
Chk1 at S345, S317 and S296; RPA2 S4/S8 and S33; Chk2T68; andH2AX
S139 after 12, 18, 36 and 72 h treatment with DMSO, 10-M polyamide
1, 1-M polyamide 2, or treatment with 30-M gemcitabine (Gcb) for 2
h or 30-M etoposide (Etop) for 2 h and 24 h in whole cell lysates. (B)
Single cell alkaline gel electrophoretic analysis DU145 cells treated with
1-M doxorubicin (Dox) for 24 h, and DMSO, 10-M polyamide 1 or 1-
M polyamide 2 for 36 h. Boxes show the median percentage of DNA in
the comet tail and are bounded by 25th and 75th percentile while whiskers
represent the min and max percentile. Four hundred cells from two biolog-
ical replicates were counted for each condition. The Mann Whitney test
reports P < 0.0001 for Dox and 2, and is indicated by *.
phosphorylation sites including Chk1 S317 and S296 and
RPA2 S33. Chk1 S317 is another target for phosphoryla-
tion by ATR in response to replication stress, and Chk1
S296 is an autophosphorylation site that is important for
its function (39). RPA2 S33 phosphorylation by ATR un-
der replication stress protects cells by stimulating DNA
synthesis and facilitates S4/S8 phosphorylation by DNA-
PKcs (38,40). After 12, 18, 36 and 72 h of treatment with
polyamide 1 or 2, neither Chk1 nor RPA2 was phosphory-
lated at any of the sites monitored (Figure 3A). To test the
possibility that polyamides 1 and 2 may somehow inhibit
ATR fromphosphorylatingChk1,DU145 cells were treated
with both polyamide 1 or 2 and aphidicolin, a DNA poly-
merase inhibitor that induces Chk1 S345 phosphorylation.
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The polyamides did not inhibit aphidicolin-induced Chk1
S345 phosphorylation (Supplementary Figure S3A and B).
The absence of Chk1 or RPA2 phosphorylation led us
to investigate phosphorylation of Chk2, another cell cy-
cle checkpoint kinase, and H2AX, a histone variant that
is phosphorylated rapidly upon DNA damage, as possible
downstream checkpoint mediators. ATM predominantly
phosphorylates Chk2 T68, though there is evidence for
phosphorylation of Chk2 by ATR following cisplatin treat-
ment (41,42). Similarly, ATM or ATR can phosphorylate
H2AX S139 in response to different types of replication
stress (43). Consistent with the absence of ATM S1981
phosphorylation after polyamide treatment, polyamides
failed to induce Chk2 T68 phosphorylation (Figure 3A).
H2AX and RPA2 S4/S8 phosphorylation were slightly ele-
vated after 72-h treatment of 1-M polyamide 2, and may
be suggestive of DNA damage. However, H2AX can be
phosphorylated under non-damaging stress (44). It is also
worth noting that these phosphorylation eventsmay be trig-
gered by apoptosis, which occurs after 72-h treatment with
polyamide 2 (Supplementary Figure S1). Finally, we also
studied the effect of high concentration polyamide treat-
ment for 18 h and similar results were observed (Supple-
mentary Figure S3C).
Py–Im polyamide treatment does not induce DNA breakage
The absence of ATM, Chk2 and RPA2 phosphorylation
suggested that polyamide-induced replication stress does
not lead to gross breakage of DNA. To study DNA break-
age directly, we treated cells with polyamides and then ana-
lyzed them by single cell alkaline gel electrophoresis (Fig-
ure 3B). Migration of the DNA from the centroid into
the ‘comet tail’ is proportional to the amount of single-
and double-strand breakage that has occurred. Cells treated
with doxorubicin, a known DNA-damaging agent, were
used as a positive control and showed a median value of
41% of total DNA in the tail. Polyamide-treated cells, how-
ever, were similar to theDMSO control withmedian%DNA
in tail values of 8 and 10 for polyamides 1 and 2, respec-
tively, compared to 6% for DMSO. The lack of extensive
DNA breakage correlates with the absence of ATM-Chk2
activation.
Py–Im polyamide treatment inducesMCM2 phosphorylation
and monoubiquitination of FANCD2, a major gatekeeper of
the FA/BRCA repair pathway
Since Chk1, Chk2 and RPA2 were not phosphorylated, our
results suggested that ATR phosphorylates targets intrin-
sic to the replication fork to regulate S-phase progression.
MCM2 is a component of the replicative helicase and is re-
quired for both initiation and elongation phases of DNA
replication. MCM2 S108 is phosphorylated by ATR and
ATM in response to stalled replication and DSBs (45). This
phosphorylation is thought to be an attempt by the cells to
promote the firing of local dormant replication origins via
Plk1 in order to ensure complete replication (46). We mon-
itored MCM2 phosphorylation for response to polyamide-
induced replication stress. Treatment with polyamide 1 or 2
resulted in a time-dependent increase ofMCM2 S108 phos-
phorylation. The level ofMCM2phosphorylation observed
Figure 4. Polyamides induce phosphorylation of MCM2 and FANCD2
monoubiquitination. (A) MCM2 S108 phosphorylation and FANCD2
monoubiquitination levels were measured in DU145 cells treated with 4-
mM HU for 2 h, and DMSO, 10-M polyamide 1 or 1-M polyamide 2
over a time course of 18, 36 and 72 h. Monoubiquitination was estimated
by normalizing the band intensity of the largemolecularweightmonoubiq-
uitinated FANCD2 band (FANCD2-L) to the low molecular weight non-
ubiquitinated FANCD2 band (FANCD2-S). (B) MCM2 S108 phosphory-
lation and FANCD2-Ub levels were measured in cells treated with 4-mM
HU for 2 h, and DMSO, 10-M polyamide 1 or 1-M polyamide 2 for 36
h with or without the addition of 2-mM caffeine. (C) MCM2 S108 phos-
phorylation and FANCD2-Ub levels were measured in cells treated with
negative control or ATR-targeting siRNA for 48 h prior to the addition of
4-mM HU for 2 h, and DMSO, 10-M polyamide 1 or 1-M polyamide
2 for 36 h.
after 36-h polyamide treatment was similar to that observed
after 2-h HU treatment. Polyamide-induced MCM2 S108
phosphorylation was also inhibited by co-treatment with
caffeine (Figure 4B). To determine the contribution of ATR
toMCM2 phosphorylation, ATRwas knocked down using
siRNA prior to polyamide treatment, and similar levels of
inhibition were observed as under caffeine treatment (Fig-
ure 4C). We also investigated the contributions of ATR and
ATM to MCM2 phosphorylation using the small molecule
kinase inhibitors NU6027 and KU55933. Both inhibitors
reduced MCM2 phosphorylation levels induced by HU or
polyamide, with a stronger effect from NU6027 (Supple-
mentary Figure S4A). Together, these observations sug-
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gest that ATR is the predominant mediator of polyamide-
induced MCM2 phosphorylation.
Recently, the FA/BRCA pathway protein FANCD2 was
implicated in a general replisome surveillance mechanism
(47). In response to replication stress, FANCD2 under-
goes ATR-dependent monoubiquitination (48), which is
critical for prolonged localization to chromatin at stalled
replication forks (47,49). FANCD2 functions to protect
stalled forks from degradation (49) and physically inter-
acts with phosphorylated MCM2 (47), though interaction
with MCM2 is not dependent upon monoubiquitination.
This led us to search for polyamide-induced monoubiq-
uitination of FANCD2 as a marker of FA/BRCA path-
way activation. Treatment with polyamide 1 or 2 caused
a time-dependent increase in monoubiquitinated FANCD2
(FANCD2-Ub) (Figure 4A). FANCD2-Ub was present in
vehicle-treated samples, which is perhaps a consequence
of DU145 cells’ endogenous genomic instability. Surpris-
ingly, inhibition of ATR through the use of caffeine or
siRNA both failed to decrease the level of polyamide-
induced FANCD2-Ub (Figure 4B and C). In addition, the
ATR inhibitorNU6027 increased the fraction of FANCD2-
Ub in response to polyamide treatment (Supplementary
Figure S4B). These results may be unique to DU145 cells,
as ATR knockdown by siRNA has been shown to abro-
gate FANCD2 ubiquitination in the presence of high lev-
els of replication fork damage caused by 12-h treatment of
HU or mitomycin C (MMC) in U2OS cells (50). The ATM
inhibitor KU55933 similarly increased FANCD2-Ub levels
when co-treated with polyamides, though this result is con-
sistent with previous studies (Supplementary Figure S4B)
(51).
Next, we confirmed the functional role of FANCD2 in
resisting the toxic effects of polyamides in a model outside
of prostate cancer. The FANCD2-deficient fibroblast cell
line PD20 complemented with an empty vector exhibited
greater sensitivity to polyamide treatment than PD20 cells
complemented with a FANCD2-expressing vector (Supple-
mentary Figure S5). Together, these data support the con-
clusion that MCM2 and FANCD2 participate in the re-
sponse to polyamide-induced replication stress in addition
to ATR.
Polyamide 1 inhibits T7 gp4A helicase activities in vitro
The results from cell culture experiments suggested a model
in which polyamides stall replication forks without causing
extensive ssDNA orDNA breaks and that the ATR and the
FA/BRCA pathways are activated. The high-affinity DNA-
binding properties of polyamides coupled with limited ss-
DNA formation suggested that polyamides might inhibit
unwinding of the replication fork. To test this hypothesis,
we determined the ability of polyamide 1 to inhibit DNA
helicases in vitro. We first studied a strong replicative, hex-
americ helicase similar to the MCM2-7 complex. Testing
both polyamides was deemed unnecessary for this particu-
lar study, as both polyamides 1 and 2 have comparable bind-
ing affinities in vitro as shown by a duplex DNA thermal
stabilization assay (Supplementary Figure S6). We used T7
gp4A, the well-studied T7 phage homohexameric replica-
tive helicase (23). We followed unwinding of a forked du-
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Figure 5. Polyamide 1 inhibits T7 gp4A helicase activity. (A) Inhibition of
T7 gp4A by polyamide 1 was tested using a forked DNA duplex contain-
ing a singlematch-binding site (top) or nomatch-binding site (bottom). 32P
is represented in the cartoon by the red asterisk. Polyamide 1 was added
in increasing concentrations (lanes 4–15): 100 pM, 300 pM, 1 nM, 3 nM,
10 nM, 30 nM, 100 nM, 300 nM, 1 M, 3 M and 10 M. (B) Graphi-
cal representation of gp4A inhibition curves. (C) Inhibition of gp4A was
then assessed in the time domain by incubating the helicase reactions for
increasing amounts of time with either the (left) matched or (right) mis-
matched substrate.
plex DNA substrate containing either a single match site
or no match sites for polyamide 1 by gel electrophoresis
(23). Helicase inhibition wasmeasured by the percent of un-
wound substrate relative to the mock-treated sample. Incu-
bating polyamide 1with the substrate containing the match
site resulted in effective inhibition of gp4A helicase activ-
ity (IC50 ∼ 5 nM) (Figure 5A, top). The polyamide was
still able to inhibit gp4A helicase activity on the mismatch
substrate but required significantly higher concentrations of
polyamide (IC50 ∼ 335 nM), owing to the sequence speci-
ficity of polyamides (Figure 5A, bottom). Similar results
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were also obtained when using a different class of helicase,
S. cerevisiae Dna2 (Supplementary Figure S7). These re-
sults suggest that the polyamide is not directly interacting
with the helicases but acts through DNA binding.
The sequence-specific non-covalent binding nature of
polyamides led us to hypothesize that helicase inhibition
would not only be stronger at a given concentration when
comparing the match to the mismatch substrate but that
the enzyme would also show slower unwinding kinetics
given the polyamide’s longer dwell time at a match site.
When using the match substrate, gp4A was unable to un-
wind as much substrate in the presence of polyamide as
the mock-treated sample even when allowed to incubate for
longer times (Figure 5C, left). However, gp4A was capa-
ble of unwinding the same amount of mismatch substrate
in the presence of polyamide as the mock-treated sample
when allowed to incubate longer (Figure 5C, right). These
data support helicase inhibition as one explanation for how
polyamides cause replication stress.
DISCUSSION
In the present study, we determine that hairpin Py–Im
polyamides designed to target the AR:DNA interface
are cytotoxic and cause replication stress in androgen-
insensitive DU145 cells. Polyamide-induced replication
stress causes the accumulation of S-phase cells and PCNA
foci, decreased replication, and triggers chromatin loading
and activation of ATR. The ssDNA-binding protein sub-
unit, RPA2, and the downstream effector kinase, Chk1,
were not phosphorylated in response to polyamide treat-
ment, even at high concentrations and after long incuba-
tions. ATR did, however, phosphorylate the MCM helicase
subunit, MCM2. In addition, the phospho-MCM2 bind-
ing partner and FA/BRCA family member, FANCD2, was
monoubiquitinated following polyamide treatment. ATR
activation also led to phosphorylation of Rad17, the ma-
jor subunit of the checkpoint clamp loader. In sum, the
polyamide-induced checkpoint response, like that induced
by nucleotide depletion, requires the general replisome
surveillance pathway involving FANCD2, but does not also
require the canonical Chk1 pathway that nucleotide deple-
tion activates to mitigate the stress. Consistent with the
DNA helix altering and duplex stabilization properties of
polyamides, we showed that polyamides inhibit a hexameric
replicative helicase in vitro and postulate a model in which
non-covalently binding polyamides intermittently preclude
replisome progression, resulting in a limited ATR check-
point response (Figure 6A).
When activated at a stalled replication fork, ATR is criti-
cal for protection of the forks from collapse. ATR also sup-
presses the firing of dormant origins globally, presumably
to prevent further replication-associated damage (6). Re-
cently, Koundrioukoff et al. (52) reported that ATR could
be activated in discrete stages. Low-concentration aphidi-
colin treatment, which resulted in moderately reduced fork
speeds, led to recruitment of ATR and ATR activators to
chromatin as well as delayed mitotic entry but did not re-
sult in ssDNA accumulation or Chk1 phosphorylation. In
addition, low concentrations of aphidicolin did not induce
ATM or H2AX phosphorylation. Based on the similar-
Figure 6. Putative model of Py–Im polyamide-induced replication stress
and subsequent ATR-dependent checkpoint response. (A) Polyamides
bind transiently atmatch sites throughout the genome, distorting the struc-
ture of the helix locally and precluding the progression of the replisome
when encountering a fork. Stalled replication fork components that were
not investigated directly (except polymerases) are outlined in dashed lines.
(B) Proposed steps of ATR checkpoint response under low replication
stress, such as polyamide treatment, or high replication stress, such as high
concentrationHU treatment.Our data support themodel for stepwise acti-
vation of ATR. First, ATR is recruited to chromatin andmoderately phos-
phorylated, leading to MCM2 phosphorylation and Rad17 phosphoryla-
tion. FANCD2 is also monoubiquitinated and recruited to chromatin for
fork protection. Then, if the stress is sufficiently high, such that replica-
tion forks are persistently stalled, ssDNA accumulation and higher ATR
T1989 phosphorylation occur, followed by downstream phosphorylation
of Chk1 by ATR. What triggers the switch leading to ssDNA accumula-
tion and ATR-Chk1 activation is unclear.
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ity in checkpoint response to polyamides, we propose that
polyamides induce low-level replication stress leading to
ATR recruitment and cell cycle delay decoupled from Chk1
activity.
Although the previous work established that activation
of the ATR checkpoint response might occur in the ab-
sence of downstream Chk1 activation, it did not iden-
tify the mediators of fork protection. Our findings im-
plicate ATR-dependent phosphorylation of MCM2 and
FA/BRCA pathway activation, as evidenced by monoubiq-
uitination of FANCD2. ATR-mediated MCM2 phospho-
rylation has previously been shown to recruit Plk1 to
stalled forks, which may allow origin firing near the stall
for completion of replication (46). FANCD2 has been
shown to bind nascent DNA at sites of replication stalling
due to nucleotide depletion and, importantly, restrains
replisome progression to minimize ssDNA accumulation
(47,53). FANCD2 bound to nascent DNA interacts tran-
siently but directly with the MCMs, including phosphory-
lated MCM2, though this interaction does not depend on
monoubiquitination of FANCD2 (47). However, this inter-
action was shown to depend on ATR activity. It is inter-
esting that polyamide-induced FANCD2 monoubiquitina-
tion in DU145 cells was not inhibited upon knockdown
of ATR. The current model of FA/BRCA pathway activa-
tion, based on studies in U2OS osteosarcoma cells, DT40
chickenB cells and in vitro assays, linksATR to downstream
FANCD2 monoubiquitination through the phosphoryla-
tion of FANCI, a FANCD2 paralog, in the presence of
catastrophic interstrand crosslinking damage or long-term
treatment with HU (48,50,54). It is possible that replica-
tion stress may trigger FANCI phosphorylation by a ki-
nase other than ATR in DU145 cells or that FANCI is
an ATR substrate under more severe forms of replication
stress. However the FA/BRCA pathway is activated, our re-
sults suggest that the FA/BRCA pathway acts in concert
with ATR-MCM2 signaling to stabilize replication forks in
response to polyamide treatment. The lack of ATR depen-
dence on polyamide-induced S-phase accumulation is also
notable, but consistent with published studies in U2OS cells
treated with HU (50). Investigating the effects of knock-
down of FA family genes on ssDNA formation and cell cy-
cle phase distribution in polyamide-treated cells would be
of interest for future studies.
In order to understand how ATR-MCM2 and
FA/BRCA activation is related to ATR-Chk1 activa-
tion, we compared the checkpoint response induced by low
replication stress, such as polyamide treatment, and high
replication stress, such as high-concentration HU treat-
ment (Supplementary Figure S8). Both treatments result
in MCM2 phosphorylation and FANCD2 monoubiqui-
tination, as well as recruitment of equivalent amounts of
ATR and its mediators to chromatin (Figure 2E). However,
polyamide treatment resulted in significantly lower levels
of ssDNA formation (Figure 2C and D). Our data suggest
that polyamide treatment either induces sufficient ssDNA
for ATR recruitment or perhaps triggers an alternative or
cooperative mechanism to recruit ATR-ATRIP to DNA.
The amount of ssDNA is also sufficient for partial ATR
activation, as indicated by Rad17 phosphorylation. We
hypothesize that only in the presence of higher levels of ss-
DNA is ATR fully activated and Chk1 phosphorylated, in
keeping with the fact that Chk1 phosphorylation depends
on the formation of long ssDNA gaps (55). Polyamide
treatment also induced much lower levels of ATR T1989
phosphorylation than did HU treatment. This correlates as
well with the lack of Chk1 phosphorylation, which requires
robust ATR T1989 autophosphorylation (31,32), and is
consistent with a model for quantitative regulation of
ATR (32). ATR T1989 phosphorylation has actually been
shown to be dispensable for ATR recruitment, Rad17 S645
phosphorylation and recovery from transient replication
stress (31,32). Based on these data, we conclude that
ATR-MCM2 and FANCD2 signaling are sufficient to
induce some fork protection. However, ATR-Chk1 cell
cycle checkpoint activation requires ssDNA accumulation
and extensive ATR T1989 phosphorylation, which is
observed under higher replication stress (Figure 6B). While
it is unclear what causes ssDNA accumulation and ATR-
Chk1 activation, some possible causes are uncoupling of
polymerase and helicase, accumulation of excess primers
or nascent DNA degradation.
A few studies have shown previously that the FA/BRCA
pathway and the ATR-Chk1 pathway serve non-redundant
functions and that their signaling mechanisms are sepa-
rable. In human primary fibroblasts, Chk1 and FANCD2
both contribute to senescence induction but Chk1 is also
responsible for persistent cell cycle arrest in response to pso-
ralen treatment (56). Similarly, knockdown of FANCD2
but not Chk1 sensitizes HeLa cells to cisplatin treatment,
despite activation of Chk1 (57). Supporting the evidence for
their different functions, it has been shown that the canon-
ical ATR activators, Rad17 and TopBP1, are necessary
for Chk1 phosphorylation but dispensable for FANCD2
monoubiquitination and FANCI phosphorylation in DT40
cells treated with MMC (58). Conversely, the FA core com-
plex is necessary for FANCD2 monoubiquitination, but is
dispensable for Chk1 phosphorylation (58). Also, the inter-
action of FANCD2 with the MCMs is not dependent on
Chk1 activity (47). Thus, the activation of the FA/BRCA
pathway but not Chk1 in response to polyamide treatment
appears to reflect a level of stress that does not require in-
tervention by Chk1.
Hairpin Py–Im polyamide-induced replication stress
causes what appears to be an intermediate state of ATR-
dependent checkpoint response. We suggest that this is due
to transient inhibition of replisome progression caused by
the polyamide’s unique high-affinity non-covalent DNA-
binding properties. This proposed mode of action distin-
guishes hairpin Py–Im polyamides from other replication
inhibitors such as HU and aphidicolin and will prove use-
ful for further dissociating the S-phase, essential ATR func-
tions from G2 checkpoint functions. Further delineation of
the S-phase-specific ATR mediators and effectors involved
in protecting replication forks can be determined as distinct
from or coordinated with those involved in cell cycle slow-
ing.
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